BRIEF-Biogen Idec says EU has approved its Plegridy drug for multiple sclerosis

July 23 Wed Jul 23, 2014 9:28am EDT

July 23 (Reuters) - Biogen Idec Inc : * Says EU has approved its Plegridy drug for multiple sclerosis. Medicine is a pegylated form of interferon given by injection once every two weeks.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.